Bank of New York Mellon’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bank of New York Mellon’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-13,475	Closed	-$143K	–	4334
2018 Q1	$143K	Sell	13,475 -843	-6%	-$13.5K	﹤0.01%	3996
2017 Q4	$604K	Buy	14,318 +714	+5%	+$32K	﹤0.01%	3523
2017 Q3	$748K	Buy	13,604 +771	+6%	+$130K	﹤0.01%	3383
2017 Q2	$2.38M	Buy	12,833 +2,725	+27%	+$478K	﹤0.01%	2751
2017 Q1	$1.21M	Buy	10,108 +15	+0.1%	+$1.57K	﹤0.01%	3140
2016 Q4	$1M	Buy	10,093 +354	+4%	+$37.3K	﹤0.01%	3262
2016 Q3	$1.09M	Buy	9,739 +714	+8%	+$85.7K	﹤0.01%	3121
2016 Q2	$928K	Buy	9,025 +2,546	+39%	+$254K	﹤0.01%	3187
2016 Q1	$596K	Buy	6,479 +135	+2%	+$14.4K	﹤0.01%	3354
2015 Q4	$915K	Buy	6,344 +4,009	+172%	+$522K	﹤0.01%	3227
2015 Q3	$242K	Buy	+2,335	New	+$274K	﹤0.01%	3841

Other funds holding SIOX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon's SIOX Position: Q2 2018 in Review

Bank of New York Mellon sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2018, closing a stake of 13,475 shares — an estimated $143K sold.

Bank of New York Mellon first reported a position in SIOX in Q3 2015 and held it in 11 quarters. The position peaked at $2.38M in Q2 2017. 71 funds tracked by Wall St. Rank hold SIOX as of Q2 2018.

Bank of New York Mellon reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Bank of New York Mellon sold 13,475 Sio Gene Therapies Inc. Common Stock shares in Q2 2018, an estimated $143K.
Bank of New York Mellon first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 11 quarters.
Bank of New York Mellon's Sio Gene Therapies Inc. Common Stock position peaked at $2.38M in Q2 2017.
71 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2018.

Based on Bank of New York Mellon's 13F filing for Q2 2018, filed 6 Aug 2018.